Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05518162 · ClinicalTrials.gov registry record · NA
Treatment of Post-partum Depression Using an Behavioral Intervention Called ROSE (Reach Out, Stay Strong, Essentials for Mothers of Newborns) Delivered Using an Electronic App
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT05518162 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 152 participants.
The verdict
NCT05518162, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
A randomized trial of pregnant people at risk for postpartum depression comparing the InBloom app (n = 76) to ROSE (n = 76; weekly scheduled group), and two control groups. We will assess Depression at baseline and 1, 2 and 3 months, ROI at 3 months, Satisfaction at 1 and 3 months and Perceived Access at 1 and 3 months. Subject participation will last up to 8 months (minimum 17 weeks pregnant through 3 months postpartum).
Interventions
- BEHAVIORAL ROSE
- DEVICE InBloom
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2023-07-17 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05518162
The ClinicalTrials.gov registry entry for NCT05518162 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ROSE is the first listed.
NCT05518162 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05518162 about?
NCT05518162 is a clinical study titled "Treatment of Post-partum Depression Using an Behavioral Intervention Called ROSE (Reach Out, Stay Strong, Essentials for Mothers of Newborns) Delivered Using an Electronic App". A randomized trial of pregnant people at risk for postpartum depression comparing the InBloom app (n = 76) to ROSE (n = 76; weekly scheduled group), and two control groups. We will assess Depression at baseline and 1, 2 and 3 months, ROI at 3 months, Satisfaction at 1 and 3 months and Perceived Acce...
What is the current status of trial NCT05518162?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2023-07-17. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT05518162?
The interventions under investigation include: ROSE (BEHAVIORAL), InBloom (DEVICE).
Who is sponsoring clinical trial NCT05518162?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.